"Making it real" - Genomics session, Vancouver, 17th, October 2018

Genomics is developing globally at a very fast rate. In almost all countries of the world, there are moves to support the development of Genomics, and to bring those developments into mainstream delivery of clinical care. As the largest global terminology, SNOMED CT is in a position to enable these developments. SNOMED CT will provide enhanced content coverage in the EHR to support both the recording of phenotypic data (essential for Genomics research) and the utility to support interoperability between the clinical EHR and Genomics researchers. To achieve these goals SNOMED CT is looking to align its content coverage of phenotypic findings with HPO through collborative efforts between both organisations. SNOMED International will also work with HPO and GA4GH to devlop and quality assure a bi-directional linkage artefact between SNOMED CT and HPO. This artefact will support the usability of EHR data by the Genomics research community, and provide utility for feeding that research back intoi EHR’s and clinical practice.

PRESENTERS

Charles Gutteridge

Charles Gutteridge is the Clinical Engagement Lead for the EMEA section of SNOMED International. Previously a clinical haematologist, medical director of Barts Health NHS Trust and National Clinical Director for Informatics, Charles is currently the Chief Clinical Information Officer for Barts Health where he leads the development and implementation of a data driven healthcare strategy for east London. Charles is working with the SNOMED International team to find ways to scale developments made in local healthcare systems for benefit in national systems of health delivery.

Richard Gain

x

Scott Campbell

x

Peter Goodhand

Peter is a leader in the global health sector as a senior executive and board member. Peter Goodhand is President of the Ontario Institute for Cancer Research (OICR) in addition to his role as CEO of the Global Alliance for Genomics and Health (GA4GH).

Peter played a key role in the creation of the GA4GH and was appointed as its founding Executive Director in 2014. Prior to this role, he was the President and CEO of the Canadian Cancer Society. Before joining the charitable sector, Goodhand had a 20 year career in the global medical technology industry, including strategic leadership roles with multinational healthcare companies such as American Cyanamid and Johnson & Johnson, and as the founding Managing Director of the Health Technology Exchange (HTX).

Ian Green

Ian is based in the UK, and has worked for SNOMED International for the last 5 years in a variety of roles. He is a nurse by background, who moved into healthcare management and then Health Informatics. Previously, he worked for the NHS in the UK, authoring both READ codes and SNOMED CT for over 10 years. In addition to a general interest in all areas of health informatics, he has a particular interest in engaging with clinicians to develop a clinical terminology that meets the requirements of all clinicians globally that can transform the way healthcare is delivered for the benefit of patients. Ian obtained an MSc in Quality in Healthcare, focusing on the implementation of evidence-based medicine and clinical governance

AM

9:00-10:30

• Introductions  (IGR)

• Session introduction (CGU)

• East London experience

• Questions

11:00-12:30

• Current SNOMED Genomics developments

  • Richard Gain –Clinithink

  • Nebraska, US (Scott Campbell)

  • Questions/discussion (CGU)

14:00-15:30

• Global picture (Peter Goodhand)

  • Organisation

  • GA4GH roadmap

  • Current status and proposed future plans (IGR)

  • Wrap-up (CGU) 

15:30-16:00 Break